Biotech & pharma
Cancer's potential on-off switch
19 May 2014
Harvard researchers use herpes virus to fight brain tumours
19 May 2014
Researchers have developed a new way to fight brain tumours by trapping oncolytic virus-loaded stem cells in a gel and then applying it directly to the malignancy
Patient stem cells used to make 'heart disease-on-a-chip'
17 May 2014
Harvard scientists have merged stem cell and 'organ-on-a-chip' technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease
Study helps unravel the tangled origin of ALS
16 May 2014
Scientists reveal structural secrets of enzyme used to make popular anti-cholesterol drug
14 May 2014
10-year study shows 'Lethal Factor' could be X-factor for new anthrax vaccine
03 May 2014
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine
Fear of math? study finds some genetic factors
29 Apr 2014
New method to analyse how cancer cells die
26 Apr 2014
Skin layer grown in lab could replace animal testing
26 Apr 2014
The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics
Researchers develop lab grown skin
26 Apr 2014
Genetic legacy from the Ottoman Empire: single mutation causes rare brain disorder
By By Bill Hathaway | 25 Apr 2014
In the 'slime jungle' height matters
24 Apr 2014
Fast way to measure DNA repair
By By Anne Trafton | MIT News Office | 22 Apr 2014
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
